Clinical Trial: A Multicenter, Open-label Study for E7040 in Japanese Subjects With Hypervascular Tumor and Subjects With Arteriovenous Malformation
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Multicenter, Open-label Study for E7040 in Japanese Subjects With Hypervascular Tumor and Subjects With Arteriovenous Malformation
Brief Summary: To evaluate the efficacy and safety of transcatheter arterial embolization with E7040 in Japanese subjects with hypervascular tumor or arteriovenous malformation
Detailed Summary:
Sponsor: Eisai Co., Ltd.
Current Primary Outcome: Success Rate of Embolization in the Target Vessel [ Time Frame: Day 1 (embolization) up to Day 30 after treatment ]
Original Primary Outcome: To evaluate the efficacy of study device with E7040, success rate of embolization in the target vessel and operability of transcatheter arterial embolization [ Time Frame: up to 12 weeks after the treatment start ]
Current Secondary Outcome: Success Rate for Operability of Embolization [ Time Frame: Day 1 (embolization) up to Day 30 after treatment ]
Original Secondary Outcome:
Information By: Eisai Inc.
Dates:
Date Received: August 30, 2012
Date Started: August 2012
Date Completion:
Last Updated: January 25, 2016
Last Verified: January 2016